Efficacy News and Research

RSS
World's largest autism science and advocacy organization awards 16 new research grants

World's largest autism science and advocacy organization awards 16 new research grants

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

Biosense Webster obtains first Ethics Committee approval for CLARITY study

Biosense Webster obtains first Ethics Committee approval for CLARITY study

Researchers show iRGD peptide increases treatment efficacy against cancer

Researchers show iRGD peptide increases treatment efficacy against cancer

Combination telaprevir treatment beneficial for retreatment of hepatitis C

Combination telaprevir treatment beneficial for retreatment of hepatitis C

Keryx Biopharmaceuticals commences Phase 3 registration clinical trial for perifosine

Keryx Biopharmaceuticals commences Phase 3 registration clinical trial for perifosine

Triclosan antibacterial found in soap in the spotlight

Triclosan antibacterial found in soap in the spotlight

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

BeaconEquity.com releases investment report on PURE

BeaconEquity.com releases investment report on PURE

OSU-CG12 agent kills cancer cells through energy restriction: Study

OSU-CG12 agent kills cancer cells through energy restriction: Study

Single vaccine for anthrax and plague: iBio confirms grant of rights

Single vaccine for anthrax and plague: iBio confirms grant of rights

Angiotech Pharmaceuticals acquires manufacturing, intellectual property rights from Haemacure

Angiotech Pharmaceuticals acquires manufacturing, intellectual property rights from Haemacure

Complex back surgeries skyrocket, raising concerns about cost, complications

Complex back surgeries skyrocket, raising concerns about cost, complications

Transcendental Meditation may reduce symptoms of depression

Transcendental Meditation may reduce symptoms of depression

Encouraging results from OptiNose's sumatriptan Phase II study for migraine

Encouraging results from OptiNose's sumatriptan Phase II study for migraine

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

MAP Pharmaceuticals initiates PD trial comparing LEVADEX to IV DHE

MAP Pharmaceuticals initiates PD trial comparing LEVADEX to IV DHE

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.